Efficacy and Safety of Epoetin Alfa in Critically Ill Patients
Top Cited Papers
- 6 September 2007
- journal article
- research article
- Published by Massachusetts Medical Society in The New England Journal of Medicine
- Vol. 357 (10), 965-976
- https://doi.org/10.1056/nejmoa071533
Abstract
Anemia, which is common in the critically ill, is often treated with red-cell transfusions, which are associated with poor clinical outcomes. We hypothesized that therapy with recombinant human erythropoietin (epoetin alfa) might reduce the need for red-cell transfusions.Keywords
This publication has 19 references indexed in Scilit:
- Red blood cell transfusions and nosocomial infections in critically ill patients*Critical Care Medicine, 2006
- Efficacy of red blood cell transfusion in the critically illCritical Care Clinics, 2004
- The CRIT Study: Anemia and blood transfusion in the critically ill—Current clinical practice in the United States*Critical Care Medicine, 2004
- Anemia and Blood Transfusion in Critically Ill PatientsJAMA, 2002
- Nutritional deficiencies and blunted erythropoietin response as causes of the Amemia of critical illnessJournal of Critical Care, 2001
- Anemia of the critically ill: “Acute” anemia of chronic diseaseCritical Care Medicine, 2000
- A Multicenter, Randomized, Controlled Clinical Trial of Transfusion Requirements in Critical CareThe New England Journal of Medicine, 1999
- Erythropoietin response is blunted in critically ill patientsIntensive Care Medicine, 1997
- RBC Transfusion in the ICUSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 1995
- Effect of stored-blood transfusion on oxygen delivery in patients with sepsisJAMA, 1993